Xinghong Gao | Immunology and Microbiology | Best Researcher Award

Prof. Xinghong Gao | Immunology and Microbiology | Best Researcher Award

Professor from Zunyi Medical University, China

Prof. Xinghong Gao is a distinguished Chinese virologist and Associate Professor at the School of Basic Medical Sciences, Zunyi Medical University. With over 15 years of research experience in molecular virology, Prof. Gao has dedicated her career to advancing our understanding of herpesviruses (KSHV, VZV, EBV, DEV, PRV) and enteroviruses (EV71, CVB3), especially focusing on epigenetic regulation of viral pathogenesis and the development of next-generation mRNA vaccines. She has led and completed over 10 national and provincial research projects and has published extensively in high-impact international journals such as Cell Death & Disease, International Journal of Biological Macromolecules, and Journal of Medical Virology. Her current research emphasizes the design of lyophilized, self-assembling nanoparticle mRNA vaccines with multivalent, high-efficiency, and low-toxicity properties, aimed at protecting both humans and animals from viral threats. Beyond research, Prof. Gao plays a critical role in teaching, mentoring, academic evaluation, and patent innovation. Her integration of virology, immunology, epigenetics, and bioengineering marks her as a leader in translational and preventive medicine. She is also actively involved in academic communities and serves as a reviewer and evaluator for journals, government agencies, and scientific committees.

Professional Profile

Education

Prof. Xinghong Gao earned her academic degrees in veterinary and biomedical sciences through a rigorous and continuous path of study in China. She began her academic journey with a Bachelor of Science in Veterinary Medicine from the College of Animal Science and Technology, Southwest University, Chongqing, from 2005 to 2009. Driven by a strong interest in virology and immunology, she pursued an integrated master’s and doctoral program (硕博连读) at the College of Veterinary Medicine, Sichuan Agricultural University, from 2009 to 2015, under the supervision of Prof. Renyong Jia. Her Ph.D. focused on preventive veterinary medicine, during which she conducted in-depth research on duck enteritis virus (DEV) and developed specialized knowledge in viral gene function and immune response mechanisms. In 2019–2020, she expanded her international exposure as a visiting scholar at the Department of Microbiology, University of Pittsburgh, USA, working under Prof. Shoujiang Gao. There, she gained advanced expertise in human herpesvirus (KSHV) pathogenesis and epigenetic regulation, further refining her molecular biology skills and laying the foundation for her ongoing work in human-animal viral infections and mRNA vaccine development.

Professional Experience

Prof. Xinghong Gao has served as Associate Professor at the School of Basic Medical Sciences, Zunyi Medical University, since January 2016. In this role, she has undertaken significant responsibilities in research, teaching, and graduate supervision. Between September 2019 and September 2020, she completed a year-long academic exchange at the University of Pittsburgh, USA, where she joined the microbiology research group of Prof. Shoujiang Gao, a renowned expert in Kaposi’s sarcoma-associated herpesvirus (KSHV). Her international experience solidified her expertise in herpesvirus biology and single-cell epigenetic analysis. At Zunyi Medical University, she leads several key research projects funded by national, provincial, and enterprise grants, many of which focus on the design of self-assembling mRNA vaccines targeting porcine and human viruses. Additionally, she teaches undergraduate and graduate courses such as pharmacology, microbiology, biosafety, and molecular biology techniques. She has also contributed to educational innovation through bilingual teaching and e-learning integration. Prof. Gao actively participates in administrative and scholarly roles, including grant and thesis evaluation, peer review, and national examination panels. Her practical approach to interdisciplinary science and teaching has earned her recognition as a versatile scholar, bridging fundamental research and public health applications.

Research Interests

Prof. Xinghong Gao’s research primarily focuses on virology, with specific expertise in the molecular mechanisms of herpesvirus and enterovirus infections. She is particularly interested in the role of epigenetic modifications—especially m6A methylation—in regulating viral replication, latency, and host-pathogen interactions. Her work with human and animal viruses (KSHV, VZV, EBV, PRV, DEV, EV71, and CVB3) aims to identify novel therapeutic and preventive strategies. A significant portion of her current research is dedicated to the development of mRNA-based vaccines using self-assembling ferritin nanoparticle delivery systems. These vaccines are designed to be multivalent, thermally stable, and low in toxicity, targeting diseases such as hand-foot-mouth disease, pseudorabies, and porcine diarrhea. Prof. Gao also explores the antiviral potential of natural compounds, including Chinese herbal formulations, further bridging traditional medicine with modern biomedical research. She integrates multi-omics methods, including transcriptomics, proteomics, methylomics, and immunomics, to gain comprehensive insights into virus-host interactions. This integrative approach allows her to develop innovative solutions to complex virological problems, with translational applications in public health, veterinary medicine, and biotechnology.

Research Skills

Prof. Gao possesses extensive technical expertise across molecular virology, vaccine development, and bioinformatics. She is skilled in a wide array of laboratory techniques, including mRNA in vitro transcription, lentiviral vector construction, single-cell and bulk transcriptomics, protein purification, and antibody generation. She is also proficient in advanced experimental methods such as co-immunoprecipitation, CRISPR-based detection, yeast two-hybrid screening, RNA interference, and RACE cloning. Her deep experience in multi-omics technologies spans DNA/RNA methylation profiling (m6A epitranscriptomics), proteomics, and full-transcriptome sequencing, which she applies to decipher the regulatory landscapes of viral pathogenesis. In vaccine research, she excels in the design and characterization of mRNA-LNP (lipid nanoparticle) platforms, particularly for lyophilized nanoparticle-based vaccines targeting herpesviruses and enteroviruses. Moreover, she has practical knowledge of cellular immunology, viral infection models, and biosafety evaluations. Prof. Gao’s technical foundation is strengthened by her fluency in scientific computing and statistical analysis. Her methodological breadth, paired with theoretical depth, enables her to lead interdisciplinary research projects and translate molecular insights into clinical and veterinary applications.

Awards and Honors

Prof. Xinghong Gao’s research excellence and academic contributions have earned her numerous awards and distinctions. She has been selected as an expert reviewer for national and provincial science foundations, including the Ministry of Science and Technology of China, the Guizhou Provincial Health Commission, and the Guangxi Provincial Department of Science and Technology. Her recognition as a trusted evaluator reflects her authority in the fields of virology, immunology, and molecular biology. She is a member of prominent professional societies such as the Chinese Society for Microbiology, Chinese Society of Immunology, Chinese Pharmacological Society, and Virology Branch of the Chinese Medical Association. Prof. Gao serves as a peer reviewer for top-tier SCI journals, including Journal of Medical Virology and Molecular Biology Reports. She is also listed as an expert in undergraduate thesis evaluation and is part of Guizhou’s high school examination panel. Additionally, she holds two authorized Chinese utility patents and is preparing an invention patent for a CRISPR-based rapid detection system. These accolades affirm her standing as a dynamic and impactful contributor to biomedical research and education in China.

Conclusion

Prof. Xinghong Gao is an accomplished biomedical researcher with a focused trajectory in molecular virology and vaccine innovation. Her dedication to exploring viral pathogenesis, epigenetic regulation, and advanced vaccine technology has produced significant scientific outputs and translational applications. With more than 15 years of hands-on research experience and a strong foundation in both veterinary and medical sciences, she has contributed over 20 high-quality publications, secured multi-level funding, and led groundbreaking work in mRNA vaccine development. Her teaching, mentoring, and technical skills further enhance her profile as a well-rounded scholar. Prof. Gao’s research aligns with critical global health priorities, including emerging viral infections and zoonotic disease control. Her contributions extend beyond laboratory success into educational reform, patent innovation, and community impact. As a result, she is not only a valuable asset to Zunyi Medical University but also a leading candidate for national and international recognition. Her profile exemplifies the integration of academic excellence, applied research, and interdisciplinary collaboration. With continued support and visibility, Prof. Gao is poised to play a transformative role in advancing preventive virology and translational biomedicine.

Publications Top Notes

  1. Title: mRNA vaccines: Emerging opportunities for herpesvirus prevention and therapeutic intervention
    Authors: Wenjie Cai, Mingsheng Cai, Mingsong Wu⁎, Xinghong Gao*
    Journal: International Journal of Biological Macromolecules, 2025

  2. Title: BSRF1 modulates IFN-β-mediated antiviral responses… in Epstein-Barr virus infection
    Authors: Shengwen Chen#, Yangxi Deng#, Chen Huang#, Xiaolei Xie#, Zhiwei Long, … Xinghong Gao, … Xi Lv(), Mingsheng Cai(), Meili Li(*)
    Journal: International Journal of Biological Macromolecules, 2025, 306: 141600

  3. Title: The advances of in vitro RNA preparation by single-subunit RNAP: A review
    Authors: Yuan Shen#, Dong-Qi Yang#, Yuan Liu, … Xinghong Gao*, Heng Xia*
    Journal: International Journal of Biological Macromolecules, 2025, 141002

  4. Title: Pregnancy induced hypertension and umbilical cord blood DNA methylation in newborns: An epigenome-wide study
    Authors: Xiaojun Zhu, Peiyue Jiang, Xia Ying, … Xinghong Gao*, Xiaofu Yang*
    Journal: BMC Pregnancy and Childbirth, 2024, 24(1): 433

  5. Title: METTL16 controls KSHV replication by regulating S-adenosylmethionine cycle
    Authors: Zhang Xinquan, Meng Wen, Feng Jian, Gao Xinghong, … Gao Shoujiang*
    Journal: Cell Death & Disease, 2023, 14(9): 591

  6. Title: Advances in mRNA vaccines for viral diseases
    Authors: Yukai Huang#, Xuerui Zhu#, Xiao Guo#, … Xinghong Gao*(通讯)
    Journal: Journal of Medical Virology, 2023, 95(7): e28924

  7. Title: Revolutionizing viral disease vaccination: Non-replicating mRNA vaccines
    Authors: Xiao Guo#, Dongying Liu#, Yukai Huang#, … Xinghong Gao*(通讯)
    Journal: Virology Journal, 2023, 20(1): 1–17

  8. Title: The crosstalk between classic signaling, ncRNAs, and ferroptosis in drug resistance
    Authors: Yang Liangyu, Chen Lei, Chen Tingting, Xinghong Gao*(通讯), Yongai Xiong*
    Journal: Cellular Signalling, 2023, 102: 110538

  9. Title: Identification of targets of JS-K against HBV-positive HepG2.2.15 cells using iTRAQ proteomics
    Authors: Liu Zhengyun, Xu Yan, Zhang Wanling, Gao Xinghong, …
    Journal: Scientific Reports, 2021, 11(1): 10381

  10. Title: Duck enteritis virus (DEV) UL54 protein interacts with DEV UL24 protein
    Authors: Xinghong Gao (First author), Renyong Jia*, Mingshu Wang, … Anchun Cheng*
    Journal: Virology Journal, 2017, 14(1): 166

Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Prof. Dr. Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Head of Research Group at Blood Transfusion Centre of Slovenia, Slovenia

Vladka Čurin Šerbec is an accomplished researcher and academic with a robust background in biochemistry, molecular biology, and immunology. With extensive experience in both academic and industrial settings, she has made significant contributions to the development of monoclonal antibodies, diagnostics, and therapeutics. Through her leadership roles, including serving as the President of the Immunology Society of Slovenia, she has influenced research in the fields of immunology and biomedicine. Her research also involves collaborations with pharmaceutical industries, leading to the development of new technologies and successful commercialization of research outcomes. Known for her mentorship of numerous students and professionals, Čurin Šerbec is a respected figure in the scientific community, contributing to the education and growth of future researchers.

Professional Profile

Education

Vladka Čurin Šerbec’s academic journey began with a BChem degree from the University of Ljubljana in 1985. She continued her studies at the same institution, obtaining a Master’s degree in Biochemistry in 1988, followed by a PhD in 1991. Throughout her education, she focused on the molecular and biochemical aspects of biology, laying the foundation for her future research in immunology and biomedicine. This strong academic background has propelled her into various prestigious positions within both academia and industry, making her a leading figure in her field.

Professional Experience

Vladka Čurin Šerbec has a distinguished career that spans several decades, beginning with her research at the Jožef Stefan Institute and the Ruđer Bošković Institute in the 1980s and 1990s. Since 1993, she has held various key positions at the Blood Transfusion Centre of Slovenia (BTCS), including Head of the Department for the Production of Diagnostic Reagents and Research, Scientific Counsellor, and Vice-President of the Supervisory Board. Additionally, she served as an Associate Professor and later a Professor at the University of Ljubljana’s Medical Faculty. Her leadership in industrial and academic collaborations has been instrumental in advancing research in immunology and biomedicine.

Research Interests

Vladka Čurin Šerbec’s research interests are centered around biochemistry, molecular biology, immunology, and the development of monoclonal antibodies for diagnostic and therapeutic purposes. Her work focuses on the production of diagnostic reagents and antibodies under GMP conditions, exploring new approaches to immunological diagnostics and treatments. Additionally, she has been involved in collaborative research with the pharmaceutical industry, contributing to the development of technologies with real-world applications. Her interest in the standardization and quality assessment of immunological diagnostics has also been pivotal to her contributions to the field.

Research Skills

Vladka Čurin Šerbec possesses a broad skill set in molecular biology, biochemistry, and immunology. Her expertise includes the development and production of monoclonal antibodies, diagnostic reagents, and research tools. She is skilled in various laboratory techniques and methodologies, including immunoassays, molecular cloning, and protein expression. Additionally, Čurin Šerbec has significant experience in project leadership, having led multiple industrial, national, and international research initiatives. Her work also involves the development of biotechnological applications, such as antibody-based diagnostics and therapeutics, in close collaboration with pharmaceutical companies.

Awards and Honors

Vladka Čurin Šerbec has received numerous awards throughout her career in recognition of her scientific achievements. Notably, she was awarded the Zois Award in 2002 for her technological innovations and contributions to the field of biochemistry. She also received the Krka Award for students in organic chemistry in 1983, highlighting her early promise as a researcher. Čurin Šerbec’s achievements have been widely acknowledged by the scientific community, and her work continues to inspire future generations of researchers. She has also been honored with leadership positions in international societies, further solidifying her reputation in the field of immunology.

Conclusion

This individual demonstrates outstanding research capabilities and leadership in the fields of biochemistry, molecular biology, and immunology. Their substantial achievements in the development of monoclonal antibodies and collaborations with industry reflect both scientific excellence and practical contributions. Their commitment to research mentoring and international collaboration further strengthens their position for recognition in research excellence. With continued focus on expanding their publication record and global research influence, they have the potential for even greater impact in the scientific community.

Publication Top Notes

  1. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
    • Authors: Song, F., Kovac, V., Mohammadi, B., Curin Serbec, V., Altmeppen, H.C.
    • Year: 2024
    • Journal: Acta Neuropathologica
    • Volume: 148(1), Pages 2
  2. Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
    • Authors: Omejec, S., Tompa, M., Kovač, V., Šerbec, V.Č.
    • Year: 2024
    • Journal: Journal of Immunological Methods
    • Volume: 534, Article 113747
  3. Prion Protein: The Molecule of Many Forms and Faces
    • Authors: Kovač, V., Šerbec, V.Č.
    • Year: 2022
    • Journal: International Journal of Molecular Sciences
    • Volume: 23(3), Article 1232
    • Citations: 21
  4. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
    • Authors: Šelb, J., Rijavec, M., Eržen, R., Lyons, J.J., Korošec, P.
    • Year: 2021
    • Journal: Journal of Allergy and Clinical Immunology
    • Volume: 148(2), Pages 621–626.e7
    • Citations: 36
  5. Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases
    • Authors: Kovač, V., Čurin Šerbec, V.
    • Year: 2018
    • Journal: Biomarker Insights
    • Volume: 13
    • Citations: 6
  6. Targeting malignant brain tumors with antibodies
    • Authors: Razpotnik, R., Novak, N., Curin Šerbec, V., Rajcevic, U.
    • Year: 2017
    • Journal: Frontiers in Immunology
    • Volume: 8(SEP), Article 1181
    • Citations: 57
  7. Truncated prion protein PrP226 – A structural view on its role in amyloid disease*
    • Authors: Kovač, V., Zupančič, B., Ilc, G., Plavec, J., Čurin Šerbec, V.
    • Year: 2017
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 484(1), Pages 45–50
    • Citations: 10
  8. New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
    • Authors: Košir, A.B., Lukan, T., Kukovec, M., Šerbec, V.Č., Rajčević, U.
    • Year: 2017
    • Journal: Zdravniski Vestnik
    • Volume: 86(5-6), Pages 177–184
  9. Anchorless forms of prion protein – Impact of truncation on structure destabilization and prion protein conversion
    • Authors: Kovač, V., Hafner-Bratkovič, I., Čurin Šerbec, V.
    • Year: 2016
    • Journal: Biochemical and Biophysical Research Communications
    • Volume: 481(1-2), Pages 1–6
    • Citations: 10
  10. Flavonoid interaction with a chitinase from grape berry skin: Protein identification and modulation of the enzymatic activity
    • Authors: Filippi, A., Petrussa, E., Rajcevic, U., Vianello, A., Braidot, E.
    • Year: 2016
    • Journal: Molecules
    • Volume: 21(10), Article 1300
    • Citations: 9

 

 

Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Dr. Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Hacettepe University Faculty of Medicine, Department of Pediatric Immunology and Allergy at Hacettepe University Faculty of Medicine, Turkey

Dr. Hilal Ünsal is a distinguished pediatric allergist and clinical immunologist specializing in the diagnosis and management of allergies and immunodeficiencies in children. With extensive training and clinical experience, Dr. Ünsal has become a prominent figure in the field of pediatric allergy, contributing significantly to both clinical practice and research. Currently pursuing advanced studies in Pediatric Allergy and Clinical Immunology at Hacettepe University, she combines her clinical expertise with a strong research background, particularly in primary immunodeficiencies, food allergies, and asthma. Her work has been published in several reputable journals, and she is an active participant in international conferences, reflecting her commitment to advancing medical knowledge and improving patient outcomes.

Professional Profile

Education

Dr. Ünsal earned her Medical Degree from Gazi University, Faculty of Medicine in 2012, where she graduated as an honor student. She then pursued a residency in pediatrics at Health Sciences University Dr. Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital, completing her training in 2018. Currently, she is completing a Clinical Fellowship in Pediatric Allergy and Clinical Immunology at Hacettepe University, a program that is enhancing her expertise in the immunologic aspects of pediatric diseases. Dr. Ünsal’s academic path reflects her dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Ünsal’s professional journey has been centered on pediatric allergy and immunology. After completing her medical education and residency, she further honed her skills in pediatric immunology during her fellowship at Hacettepe University, one of Turkey’s leading medical institutions. Over the years, Dr. Ünsal has actively contributed to the diagnosis and management of pediatric allergies, asthma, and immunodeficiencies, working in various clinical settings. Her experience spans the diagnosis of IgE-mediated food allergies, asthma exacerbations, and immunodeficiencies, as well as advanced research in these areas. She has gained a reputation for her meticulous approach to clinical research and patient care.

Research Interests

Dr. Ünsal’s research focuses on the intricate relationships between primary immunodeficiencies, genetics, and pediatric allergies. Her specific interests include food allergies, drug allergies, allergic rhinitis, and asthma, with a strong emphasis on understanding the genetic and immunological factors contributing to these conditions in children. She is particularly dedicated to identifying novel allergens and improving diagnostic methods for food allergies, as well as exploring the role of oxidative stress in asthma. Through her research, Dr. Ünsal aims to improve the quality of life for children suffering from these conditions by enhancing early diagnosis, treatment strategies, and prevention methods.

Research Skills

Dr. Ünsal has developed robust research skills, particularly in the areas of biostatistics, immunological testing, and clinical research methodologies. She is proficient in using SPSS for data analysis, enabling her to conduct rigorous statistical evaluations of her research data. Her research skills are further enhanced by her involvement in multiple projects on food allergies, asthma, and immunodeficiencies. Dr. Ünsal’s expertise in interpreting complex immunological data, along with her ability to work with diverse patient populations, has allowed her to contribute to significant studies in her field. Her active participation in both clinical and experimental research ensures that her work remains at the forefront of pediatric allergy and immunology.

Awards and Honors

Dr. Ünsal’s academic and research excellence has been recognized by her peers and academic institutions. As an honor student at Gazi University, she demonstrated early promise in her medical career. Her ongoing contributions to the field of pediatric allergy and immunology have earned her opportunities to present at numerous prestigious conferences, including the European Academy of Allergy and Clinical Immunology (EAACI) Congress and the World Allergy Congress. Additionally, her research has been published in well-regarded journals such as Pediatric Allergy and Immunology and Turkish Journal of Medical Sciences, which highlights her commitment to advancing knowledge in her field.

Conclusion

Dr. Hilal Ünsal is highly deserving of the Best Researcher Award based on her extensive body of work, leadership in research, and active participation in international conferences. Her expertise in pediatric immunology and allergy is well-documented, and her ongoing research in immunodeficiencies and food allergies is crucial for advancing clinical practice in these areas. While further strengthening her clinical impact and broadening her research funding could enhance her profile, her current contributions to the field place her as a prominent figure in her discipline. Dr. Ünsal is well-positioned for continued excellence in research, making her an excellent candidate for this prestigious award

Publication Top Notes

  1. Title: The treatment journey of children with moderate to severe atopic dermatitis in Türkiye: unmet needs
    • Authors: İlgün Gürel, D., Ünsal, H., Soyak Aytekin, E., Ersoy Evans, S., Şekerel, B.E.
    • Year: 2024
  2. Title: A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey
    • Authors: Ünsal, H., Caka, C., Bildik, H.N., Tezcan, İ., Çağdaş, D.
    • Year: 2024
    • Citations: 2
  3. Title: Cupressus arizonica: an emerging aeroallergen for East Mediterranean children
    • Authors: Ünsal, H., Şahiner, Ü.M., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
  4. Title: Phenotypes of persistent hen’s egg allergy in children and adolescents
    • Authors: Ünsal, H., Dal, S.T., Akarsu, A., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
    • Citations: 2
  5. Title: Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma
    • Authors: Soyak Aytekin, E., Sahiner, U.M., Tuten Dal, S., Sekerel, B.E., Soyer, O.
    • Year: 2022
    • Citations: 9
  6. Title: IgE mediated legume allergy in east Mediterranean children: A reflection of multiple food allergies
    • Authors: Soyak Aytekin, E., Unsal, H., Sahiner, U.M., Soyer, O., Sekerel, B.E.
    • Year: 2022
    • Citations: 4
  7. Title: Comparison of miRNA expression in patients with seasonal and perennial allergic rhinitis and non-atopic asthma
    • Authors: Tunçer, F., Şahiner, Ü.M., Ocak, M., Şekerel, B.E., Birben, E.
    • Year: 2022
    • Citations: 4
  8. Title: Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients
    • Authors: Sekerel, B.E., Unsal, H., Sahiner, U.M., Karakaya, G., Kalyoncu, A.F.
    • Year: 2022
    • Citations: 5
  9. Title: Food allergy management has been negatively impacted during the COVID-19 pandemic
    • Authors: Soyak Aytekin, E., Tüten Dal, S., Ünsal, H., Soyer, Ö., Şekerel, B.E.
    • Year: 2021
    • Citations: 2
  10. Title: Allergic reactions against COVID-19 vaccines
    • Authors: Ünsal, H., Şekerel, B.E., Şahiner, Ü.M.
    • Year: 2021
    • Citations: 4

 

Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain

Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine.

Profile

Education

Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences.

Professional Experience

Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology.

Research Interest

Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science.

Research Skills

Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care.

Award and Recognition

Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research.

Conclusion

Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award.

Publication Top Notes

  1. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study
    • Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F.
    • Year: 2024
    • Journal: HLA
  2. CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
    • Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M.
    • Year: 2023
    • Journal: Frontiers in Bioscience – Landmark
    • Citations: 1
  3. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
    • Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M.
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Citations: 5
  4. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
    • Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M.
    • Year: 2023
    • Journal: Frontiers in Immunology
    • Citations: 4
  5. Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor
    • Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F.
    • Year: 2022
    • Journal: HLA
    • Citations: 2
  6. The age again in the eye of the COVID-19 storm: evidence-based decision making
    • Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J.
    • Year: 2021
    • Journal: Immunity and Ageing
    • Citations: 7
  7. The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor
    • Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A.
    • Year: 2021
    • Journal: HLA
    • Citations: 2
  8. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome
    • Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M.
    • Year: 2021
    • Journal: Current Protein and Peptide Science
    • Citations: 2
  9. Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain
    • Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R.
    • Year: 2021
    • Journal: Human Immunology
    • Citations: 1
  10. Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study
    • Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M.
    • Year: 2021
    • Journal: Journal of Clinical Medicine
    • Citations: 14